B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-β-directed IgA switching and changes in B cell fate

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2389-2396

  Klein, Jörg ^a   Ju, Wenjun ^b   Heyer, Jörg ^b   Wittek, Britta ^a,d   Haneke, Torsten ^a   Knaus, Petra ^a,e   Kucherlapati, Raju ^c   Böttinger, Erwin P ^b   Nitschke, Lars ^a,f   Kneitzini, Burkhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HAMBURG   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; LIPOPOLYSACCHARIDE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL FATE; CONTROLLED STUDY; GASTRULATION; GENE INACTIVATION; GENE REARRANGEMENT; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PERITONEUM CELL; PEYER PATCH; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN;

EID: 32044468317     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2389     Document Type: Article

References (40)

1. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425: 577-584.
2. Dennler, S., M. J. Goumans, and P. ten Dijke. 2002. Transforming growth factor β signal transduction. J. Leukocyte Biol. 71: 731-740.
3. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
4. de Caestecker, M. P., W. T. Parks, C. J. Frank, P. Castagnino, D. P. Bottaro, A. B. Roberts, and R. J. Lechleider. 1998. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12: 1587-1592.
5. Yagi, K., D. Goto, T. Hamamoto, S. Takenoshita, M. Kato, and K. Miyazono. 1999. Alternatively spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274: 703-709.
6. Siegel, P. M., and J. Massague. 2003. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3: 807-821.
7. Wolfraim, L. A., T. M. Fernandez, M. Mamura, W. L. Fuller, R. Kumar, D. E. Cole, S. Byfield, A. Felici, K. C. Flanders, T. M. Walz, et al. 2004. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N. Engl. J. Med. 351: 552-559.
8. Riggins, G. J., K. W. Kinzler, B. Vogelstein, and S. Thiagalingam. 1997. Frequency of Smad gene mutations in human cancers. Cancer Res. 57: 2578-2580.
9. Weinstein, M., X. Yang, C. Li, X. Xu, J. Gotay, and C. X. Deng. 1998. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci. USA 95: 9378-9383.
10. Nomura, M., and E. Li. 1998. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393: 786-790.
11. Yang, X., C. Li, X. Xu, and C. Deng. 1998. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA 95: 3667-3672.
12. Sirard, C., J. L. de la Pompa, A. Elia, A. Itie, C. Mirtsos, A. Cheung, S. Hahn, A. Wakeham, L. Schwartz, S. E. Kern, et al. 1998. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12: 107-119.
13. Yang, X., J. J. Letterio, R. J. Lechleider, L. Chen, R. Hayman, H. Gu, A. B. Roberts, and C. Deng. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18: 1280-1291.
14. Zhu, Y., J. A. Richardson, L. F. Parada, and J. M. Graff. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94: 703-714.
15. Datto, M. B., J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X. F. Wang. 1999. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol. 19: 2495-2504.
16. Kaminski, D. A., J. J. Letterio, and P. D. Burrows. 2002. Differential regulation of mouse B cell development by transforming growth factor β1. Dev. Immunol. 9: 85-95.
17. Sonoda, E., R. Matsumoto, Y. Hitoshi, T. Ishii, M. Sugimoto, S. Araki, A. Tominaga, N. Yamaguchi, and K. Takatsu. 1989. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170: 1415-1420.
18. Cazac, B. B., and J. Roes. 2000. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13: 443-451.
19. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
20. Ju, W., A. Ogawa, J. Jeyer, D. Nierhof, L. Yu, R. Kucherfapati, D. A. Shafritz, and E. P. Bortinger, 2006. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol. 26: 654-667.
21. Ishisaki, A., K. Yamato, S. Hashimoto, A. Nakao, K. Tamaki, K. Nonaka, P. ten Dijke, H. Sugino, and T. Nishihara. 1999. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J. Biol. Chem. 274: 13637-13642.
22. Brunner, C., D. Marinkovic, J. Klein, T. Samardzic, L. Nitschke, and T. Wirth. 2003. B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice. J. Exp. Med. 197: 1205-1211.
23. Kinoshita, K., M. Harigai, S. Fagarasan, M. Muramatsu, and T. Honjo. 2001. A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc. Natl. Acad. Sci. USA 98: 12620-12623.
24. Randall, R. A., M. Howell, C. S. Page, A. Daly, P. A. Bates, and C. S. Hill. 2004. Recognition of phosphorylated-Smad2-containing complexes by a novel Smad interaction motif. Mol. Cell. Biol. 24: 1106-1121.
25. Yamaguchi, K., K. Shirakabe, H. Shibuya, K. Irie, I. Oishi, N. Ueno, T. Taniguchi, E. Nishida, and K. Matsumoto. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270: 2008-2011.
26. Perlman, R., W. P. Schiemann, M. W. Brooks, H. F. Lodish, and R. A. Weinberg. 2001. TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3: 708-714.
27. Gonnella, P. A., Y. Chen, J. Inobe, Y. Komagata, M. Quartulli, and H. L. Weiner. 1998. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 160: 4708-4718.
28. Snider, D. P., H. Liang, I. Switzer, and B. J. Underdown. 1999. IgA production in MHC class II-deficient mice is primarily a function of B-1a cells. Int. Immunol. 111: 191-198.
29. Fagarasan, S., K. Kinoshita, M. Muramatsu, K. Ikuta, and T. Honjo. 2001. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413: 639-643.
30. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
31. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
32. Samardzic, T., D. Marinkovic, C. P. Danzer, J. Gerlach, L. Nitschke, and T. Wirth. 2002. Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol. 32: 561-567.
33. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14: 603-615.
34. 2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J. Exp. Med. 197: 1689-1699.
35. Roes, J., B. K. Choi, and B. B. Cazac. 2003. Redirection of B cell responsiveness by transforming growth factor β receptor. Proc. Natl. Acad. Sci. USA 100: 7241-7246.
36. Waf1/Cip1 regulation by transforming growth factor-β. J. Biol. Chem. 275: 29244-29256.
37. Chen, C. R., Y. Kang, P. M. Siegel, and J. Massague. 2002. E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell 110: 19-32.
38. 1 arrest through modulation of IL-2 responsiveness. J. Immunol. 173: 3093-3102.
39. Bouchard, C., W. H. Fridman, and C. Sautes. 1997. Effect of TGF-β1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes. J. Immunol. 159: 4155-4164.
40. Kip1 mRNA and protein in murine B cells. J. Immunol. 160: 770-777.